Pretreatment with brain natriuretic peptide reduces skeletal muscle mitochondrial dysfunction and oxidative stress after ischemia-reperfusion. J Appl Physiol 114: 172-179, 2013. First published October 25, 2012 doi:10.1152/japplphysiol.00239.2012 reduces the extent of myocardial infarction. We aimed to determine whether BNP may reduce skeletal muscle mitochondrial dysfunctions and oxidative stress through mitochondrial KATP (mKATP) channel opening after ischemia-reperfusion (IR). Wistar rats were assigned to four groups: sham, 3-h leg ischemia followed by 2-h reperfusion (IR), pretreatment with BNP, and pretreatment with 5-hydroxydecanoic acid, an mKATP channel blocker, before BNP. Mitochondrial respiratory chain complex activities of gastrocnemius muscles were determined using glutamate-malate (V max), succinate (V succ), and N,N,N=,N=-tetramethyl-p-phenylenediamine dihydrochloride ascorbate (V TMPD/asc). Apoptosis (Bax-toBcl2 mRNA ratio and caspase-3 activity) and oxidative stress (dihydroethidium staining) were also assessed. Compared with the sham group, IR significantly decreased V max, reflecting complex I, II, and IV activities (Ϫ36%, 3.7 Ϯ 0.3 vs. 5.8 Ϯ 0.2 mol O2·min Ϫ1 ·g dry wt Ϫ1 , P Ͻ 0.01), and V TMPD/asc, reflecting complex IV activity (Ϫ37%, 8.6 Ϯ 0.8 vs. 13.7 Ϯ 0.9 mol O2·min Ϫ1 ·g dry wt Ϫ1 , P Ͻ 0.01). IR increased Bax-to-Bcl2 ratio (ϩ57%, 1.1 Ϯ 0.1 vs. 0.7 Ϯ 0.1, P Ͻ 0.05) and oxidative stress (ϩ45%, 9,067 Ϯ 935 vs. 6,249 Ϯ 723 pixels, P Ͼ 0.05). BNP pretreatment reduced the above alterations, increasing V max (ϩ38%, P Ͻ 0.05) and reducing Bax-to-Bcl2 ratio (Ϫ55%, P Ͻ 0.01) and oxidative stress (Ϫ58%, P Ͻ 0.01). BNP protection against deleterious IR effects on skeletal muscles was abolished by 5-hydroxydecanoic acid. Caspase-3 activities did not change significantly. Conversely, BNP injected during ischemia failed to protect against muscle injury. In addition to maintaining the activity of mitochondrial respiratory chain complexes and possibly decreasing apoptosis, pretreatment with BNP protects skeletal muscle against IR-induced lesions, most likely by decreasing excessive production of radical oxygen species and opening mK ATP channels.
The mechanisms implicated in IR pathophysiology are highly dependent on mitochondrial function, the main energy source of cells. Indeed, prolonged IR in skeletal muscle has been found to significantly impair mitochondrial respiratory chain complex activities (6, 44) , reduce adenosine diphosphate-activated respiratory activity (state 3), decrease inner membrane potential and basal respiration (3, 34) , and increase cytosolic/mitochondrial calcium overload (10, 26) . Before cell death, increased radical oxygen species (ROS) induce cell membrane alterations, edema (18) , and microvascular lesions (41) . Apoptosis, an energy-requiring process resulting in nuclear fragmentation and cytoplasmic condensation, contributes to cell death and is also partly activated by a mitochondrial pathway initiated during ischemia and subsequently amplified during reperfusion (15, 31) . Mitochondria are the cornerstones of the IR injury process, as well as targets for protective strategies (6, 44) . Thus mitochondrial K ATP (mK ATP ) channel opening has been shown to participate in the beneficial effects of preconditioning on different organs, including skeletal muscles (9, 29) .
B-type natriuretic peptide (BNP), a hormone mainly secreted by the heart, is generally increased in the presence of impaired hemodynamic states and inflammation (43) , such as congestive heart failure and circulatory shock (33, 40) . It has been successfully used to decrease cardiac filling pressure and/or increase glomerular filtration rate (13, 17, 52) .
At the subcellular level, D'Souza et al.
were the first to demonstrate that BNP/mK ATP channel signaling constitutes an important injury-limiting mechanism during myocardial ischemia (11) . Therefore, modulating BNP level may be an interesting therapeutic approach in patients suffering from IR-induced skeletal muscle alterations. Accordingly, although there are no data on a potential protective effect of BNP on skeletal muscles submitted to IR, BNP is known to inhibit apoptotic DNA fragmentation and to prolong survival of serum-deprived pheochromocytoma-derived PC12 cells (14) .
Unlike the myocardium, the role of BNP during IR inducedskeletal muscle injuries has never been previously studied, to our knowledge.
The aim of the present study was, therefore, to determine, for the first time, whether pretreatment with BNP might protect hindlimb skeletal muscle against IR injuries, thereby preserving mitochondrial respiratory chain complex activities and reducing apoptosis. We hypothesized that BNP protection possibly involves mK ATP channel opening and reduced ROS production. We additionally investigated whether BNP injected during ischemia also displays protective properties.
MATERIALS AND METHODS

Animals
This study conforms to the European institutional guidelines for ethical animal treatment and was approved by the Animal Care Committee of the University of Strasbourg (C.R.E.M.E.A.S. no. AL/04/08/05/09). Experiments were performed on 44 adult male Wistar rats (Depré, France) weighing Ϸ 250 -350 g. Animals were housed in a neutral temperature environment (22 Ϯ 2°C) on a 12:12-h photoperiod and were provided food and water ad libitum.
Surgical Preparation and Procedures
Rats were anesthetized with an intraperitoneal injection of pentobarbital sodium (55 mg/kg body wt) and tracheotomized with a 14-gauge cannula for mechanical ventilation (SAR 830/P Small Animal Ventilator, CWE, Ardmore, Pa) (ambient air, 50 ml/min respiratory rate). The adequacy of anesthesia was monitored by a periodic observation of mucous membrane color, adequate mechanical ventilation adaptation, and loss of pedal reflex; when necessary, additional intraperitoneal injections of pentobarbital sodium were required during the surgical procedure to maintain deep anesthesia. Heart rate was continuously monitored during the protocol in all animals with three transcutaneous electrodes (Power Lab/16 SP, CHART V.4.1.2 software).
Each rat was placed on an electric blanket to maintain body temperature at 37°C, which was monitored by a rectal probe throughout the experiment (Homeothermic Blanket Control Unit, Harvard Apparatus, Holliston, MA). As this procedure was performed entirely under general anesthesia from which the animal did not recover consciousness (i.e., "nonrecovery" procedure), animals were euthanized by pentobarbital sodium overdose at the end of experiment to ensure a minimum of pain, suffering, and distress.
Study Design
Thirty-eight rats were divided into four groups: the sham group (SH, n ϭ 8) underwent 6 h of general anesthesia and surgical manipulation similar to that performed in the three other groups, with the exception of hindlimb ischemia, which was not induced. The IR group (n ϭ 10) underwent 3 h of ischemia, induced by a rubber-band tourniquet applied on the right root of the hindlimb, followed by a reperfusion period of 2 h. Ischemia was clinically characterized by cyanosis and lack of arterial pulse distal to the clamp. During reperfusion, the arterial pulse reappeared. Pharmacological preconditioning was performed in the third group (BNP-IR, n ϭ 10) by two subcutaneous 5 g/kg BNP injections 60 and 30 min before IR in the right foreleg. We compared both ischemic and nonischemic contralateral leg mitochondrial functions to investigate an eventual effect of BNP per se. In the fourth group, 10 min before the BNP protocol, 5-hydroxydecanoic acid (5-HD-BNP-IR, 5 mg/kg, n ϭ 10), reputed to specifically block mK ATP channels, was injected intraperitoneally (Fig. 1 ).
An additional experiment was also performed to determine whether BNP might be protective if administrated later, during ischemia. Thus identical doses of subcutaneous BNP were given at 60 min and 90 min of ischemia (BNP2, n ϭ 6). Mitochondrial respiratory chain complex activities were compared in both the ischemic leg (BNP2-IR) and the nonischemic contralateral leg (BNP2-CL). Indeed, previous studies have demonstrated that the contralateral leg can be used as a control when performing unilateral leg ischemia (45) .
Tissue Processing of Skeletal Muscles
At the end of the procedure, white superficial gastrocnemius muscles were excised and cleansed of adipose and connective tissues.
One portion was used immediately for studying mitochondrial respiration, while the remainder was frozen in isopentane cooled by liquid nitrogen and stored for subsequent analysis.
Study of Muscle Mitochondrial Respiration
Measuring oxygen consumption ex vivo in skinned fibers is a unique means to determine the functional oxidative capacity of the skeletal muscle, allowing the study of the entire mitochondrial population within its cellular environment. A schematic representation of the mitochondrial respiratory chain with specific substrates and inhibitors, as well as of oxygraph traces, is presented in Fig. 2 .
Briefly, the mitochondrial respiration was studied in saponinskinned fibers of the white gastrocnemius, as previously described (53) . Fibers were separated and permeabilized in a bath of solution S containing 50 g/ml saponin for 30 min at 4°C, under gentle shaking. Permeabilized fibers were then washed for 10 min, to remove saponin, and placed in a bath with the respiratory solution for two 5-min periods, to remove all phosphates. Finally, oxygen consumption was measured polarographically using a Clark-type electrode in a 3-ml oxygraphic cell (Strathkelvin Instruments, Glasgow, UK). Basal oxygen consumption (V 0), and maximal fiber respiration (V max) rates were measured at 22.1°C under continuous stirring in the presence of saturating amount of adenosine diphosphate as a phosphate acceptor.
The relative contributions of the respiratory chain complexes I, III, and IV to the global mitochondrial respiratory rates were also determined. When V max was recorded, electron flow went through complexes I, III, and IV. Complex I was blocked with amytal (0.02 mM), and complex II was stimulated with succinate (25 mM) to investigate complex II, III, IV activities (V succ). Thereafter, N,N,N=,N=-tetramethyl-p-phenylenediamine dihydrochloride (TMPD, 0.5 mM) and ascorbate (0.5 mM) were added as an artificial electron donor to cytochrome c. Under these conditions, the activity of cytochrome-c oxidase (complex IV) was determined as an isolated step of the respiratory chain (V TMPD/asc).
Fibers were then harvested and dried for 15 min at 150°C. Respiration rates were expressed as micromoles of O2 per minute per gram dry weight. 
Dihydroethidium Staining
To detect the presence of ROS in skeletal muscles, 10-m-thick serial sections were cut on a cryostat microtome and thaw-mounted onto glass slides. After air-drying, slides were incubated (30 min at 37°C) with 2.5 mol/l dihydroethidium (DHE) in phosphate-buffered saline. DHE produces red fluorescence when oxidized to ethidium bromide by ROS, including superoxide anion (30) . After staining, sections were rinsed, air dried, mounted in Vectashield (Vector Laboratories, Burlingame, CA), and coverslipped. They were examined under an epifluorescence microscope (Nikon Eclipse E800) with a ϫ20 epifluorescence objective, and the emission signal was recorded with a Zeiss 573-637 nm filter. Micrographs were analyzed with Adobe Photoshop 6.0 (USA).
Apoptosis Analysis by Bax/Bcl2 Quantitative Real-Time Polymerase Chain Reaction
Total RNA was extracted from muscle using a commercially available TRIzol Reagent kit (Invitrogen Life Technologies, Rockville, MD), as previously described (50) . Briefly, Ͻ100 mg of muscle were removed from the freezer and immediately immersed in 1 ml of TRIzol reagent. The muscle was homogenized on ice using a glass homogenizer, and the aqueous and organic phases were separated using 200 l of chloroform. Total RNA was precipitated using 600 l of isopropyl alcohol, washed twice with ethanol, redissolved in 10 l of diethyl pyrocarbonate-treated H 2O and stored at Ϫ80°C. The concentration and purity of the RNA was determined using a Nanodrop by measuring the absorbance at 260 and 280 nm.
RT was performed on 2 g of total RNA using a commercially available kit (Invitrogen Life Technologies). Total RNA was converted to cDNA using reverse transcriptase in a reaction volume of 20 l containing 1ϫ reaction buffer, 10 mM dNTP, 20 g of random primer p(dN)6, 0.5 l of reverse transcriptase, and water. RT was performed in a thermal cycler with a profile of 65°C for 5 min, 42°C for 50 min, and 72°C for 15 min. All samples were run together. Following RT, samples were stored at Ϫ20°C until analysis. Realtime PCR measurement of individual cDNAs was performed in duplicate using SYBR green dye (Invitrogen Life Technologies) containing 10 M of each primer (sense and antisense), to measure duplex DNA formation with the LightCycler System (Roche Diagnostics, Meylan, France). Primer sequences were designed using information contained in the public database in the GeneBank of the National Center for Biotechnology Information. The sequences of primer sets used are listed in Table 1 . Quantification of gene expression was carried out by the method described by Liu and Saint (25), using GCB gene as inner control, which is the most stable gene for real-time PCR measurements in skeletal muscle. Indeed, this GCB housekeeping gene has previously been validated and used in prior studies examining gene expression in skeletal muscle (53) . Amplification efficiency of each sample was calculated as previously described (38) , and relative mRNA expression levels were calculated using the ⌬⌬CT method.
Apoptosis Analysis by Caspase-3 Activity Assay
Frozen muscle samples (ϳ0.1 g) were homogenized in 500 l of extraction buffer containing 10 mM Tris·HCl (pH 7.5), 0.1 M NaCl, 1.0 mM EDTA, and 0.0001% Triton X-100. Samples were then frozen overnight at Ϫ20°C. Samples were thawed and centrifuged at 12,000 g for 5 min. The assay was then carried out according to the kit protocol (EnzChek Caspase-3 Assay Kit, Molecular Probes, Invitrogen, Carlsbad, CA) (37, 48) . Briefly, 50 l of tissue homogenate were incubated with 50 l of Z-DEVD-AMC substrate at 37°C for 1 h. Fluorescence was measured with a Victor3 Wallac 1,420 multilabel counter (PerkinElmer) with excitation and emission wavelengths of 355 and 460 nm, respectively. A portion of tissue homogenate was incubated with the caspase-3 inhibitor Ac-DEVD-CHO, in which an inhibited fluorescent signal was observed. Caspase-3 activity was expressed in percentage of control group.
Chemicals
BNP-32 (rat) and 5-HD were purchased from Bachem AG (Bubendorf, Switzerland) and Sigma-Aldrich (Steinheim, Germany), respectively.
Statistical Analysis
All data are expressed as means Ϯ SE and analyzed using Prism database (GraphPad Prism 5, Graph Pad Software, San Diego, CA). A one-way ANOVA was used in all groups for mitochondrial respiratory function, ROS production, and apoptosis analysis, followed by Newman-Keuls post hoc test between groups for multiple comparisons. Intragroup mitochondrial respiratory function comparisons (IR vs. CL) were performed by using a paired t-test.
A P value Ͻ0.05 was considered significant. Bottom: schematic oxygraph traces depicting oxygen consumption by the permeabilized skeletal myofibers, using indicated substrates and inhibitors. V I, minute ventilation; V 0, basal oxygen consumption; V max, complex I, III, and IV activities, using glutamate-malate; V s, complex II, III, and IV activities, using succinate; V TMPD/asc, mainly complex IV activity using TMPD/ascorbate, as mitochondrial substrates.
RESULTS
There were no differences between animals with regard to age, weight, and body temperature.
IR Reduced Mitochondrial Respiratory Chain Complex Activities and Increases Bax-to-Bcl2 mRNA Ratio and Oxidative Stress
IR decreased mitochondrial respiratory chain complex activities in the ischemic leg. See Fig. 3 . In the glycolytic gastrocnemius muscle, maximal oxidative capacities (V max ) reflecting complex I, III, IV activities were significantly impaired after IR, compared with the SH group (Ϫ36%,
Ϫ1 ·g dry wt Ϫ1 , P Ͼ 0.05). Finally, V TMPD/asc , reflecting complex IV activity, was significantly decreased after IR compared with the SH group (Ϫ37%, 8.6 Ϯ 0.8 vs. 13.7 Ϯ 0.9 mol O 2 ·min Ϫ1 ·g dry wt Ϫ1 , P Ͻ 0.01).
IR likely increased apoptosis. See Fig. 4 . IR likely increased apoptosis, as reflected by a significantly higher gene expression of Bax-to-Bcl2 mRNA ratio (Bax/Bcl2 mRNA) compared with the SH group (ϩ57%, 1.1 Ϯ 0.1 vs. 0.7 Ϯ 0.1, P Ͻ 0.05).
IR also increased oxidative stress. See Fig. 5 . To examine the implication of oxidative stress, DHE staining was used as an approach for measuring ROS production (and particularly superoxide anion). In gastrocnemius muscles, IR tended to increase the level of fluorescence compared with the SH group (ϩ45%, 9,067 Ϯ 935 vs. 6,249 Ϯ 723 pixels, P Ͼ 0.05). , P ϭ 0.12, for the ischemic leg and the nonischemic contralateral leg, respectively).
Pretreatment with BNP Protected Skeletal Muscles
Effect of BNP on apoptosis. See Fig. 4 . The gene expression of Bax/Bcl2 mRNA was significantly decreased in the BNP-IR group compared with the IR group (Ϫ55%, 0.5 Ϯ 0.1 vs. 1.1 Ϯ 0.1, P Ͻ 0.01), whereas it was comparable in BNP-IR and SH groups. These results suggest an antiapoptotic effect of BNP. Nevertheless, no statistical difference was found between the different groups with regard to caspase-3 activities (100.0 Ϯ 13.6, 59.4 Ϯ 18.8, 113.3 Ϯ 5, and 81.2 Ϯ 30.8% of SH group for SH, IR, BNP-IR, and 5-HD-BNP-IR groups, respectively).
BNP reduced oxidative stress after IR. See Fig. 5 . DHE staining reflecting ROS production was significantly reduced in the BNP group compared with the IR group (Ϫ58%, 9,067 Ϯ 935 vs. 3,832 Ϯ 774 pixels, P Ͻ 0.01). Conversely, DHE staining was similar between BNP-IR and SH groups.
Involvement of mK ATP Channel Opening in the Protective Effects of BNP
Globally, pretreatment with 5-HD inhibited all protective effects of BNP on IR-induced deleterious effects.
Involvement of mK ATP channel in BNP-induced mitochondrial respiratory chain complex protection. See Fig. 3 . The protective effect of BNP on the mitochondrial respiratory function was abolished by the administration of 5-HD pretreatment. Indeed, V max and V TMPD/asc were significantly decreased in the 5HD-BNP-IR group compared with both SH (Ϫ36%, 3.7 Ϯ 0.3 vs. 5.8 Ϯ 0.2 mol O 2 ·min Ϫ1 ·g dry wt
Ϫ1
, P Ͻ 0.01 and Ϫ28%, 9.8 Ϯ 0.5 vs. 13.7 Ϯ 0.9 mol O 2 ·min Ϫ1 ·g dry wt Ϫ1 , P Ͻ 0.01, respectively) and BNP-IR groups (Ϫ27%, 3.7 Ϯ 0.3 vs. 5.1 Ϯ 0.5 mol O 2 ·min Ϫ1 ·g dry wt
, P Ͻ 0.05 and Ϫ35%, 9.8 Ϯ 0.5 vs. 15.0 Ϯ 1.3 mol O 2 ·min Ϫ1 ·g dry wt Ϫ1 , P Ͻ 0.001, respectively). V succ tended to be decreased in the 5HD-BNP-IR group compared with the BNP-IR group (Ϫ28%, 4.3 Ϯ 0.2 vs. 5.5 Ϯ 0.5 mol O 2 ·min Ϫ1 ·g dry wt Ϫ1 , P Ͼ 0.05).
Involvement of mK ATP channel in BNP-induced apoptosis prevention. See Fig. 4 . Gene expression of Bax/Bcl2 mRNA in the 5HD-BNP-IR group was significantly greater than in both SH and BNP-IR groups (ϩ42%, 1.0 Ϯ 0.1 vs. 0.7 Ϯ 0.1, P Ͻ 0.05, and ϩ100%, 1.0 Ϯ 0.1 vs. 0.5 Ϯ 0.1, P Ͻ 0.01, respectively).
Involvement of mK ATP channel in BNP-induced oxidative stress reduction. See Fig. 5 . ROS production was significantly increased in the 5HD-BNP-IR group compared with the BNP-IR group (ϩ183%, 10,865 Ϯ 1,827 vs. 3,832 Ϯ 774 pixels, P Ͻ 0.01). On the other hand, the level of ROS in the 5HD-BNP-IR group was comparable to that of the IR group.
BNP Administered During Ischemia Failed to Protect Mitochondrial Respiratory Chain Complex Activities
See Fig. 6 . Despite BNP therapy, V max , V succ , and V TMPD/asc were significantly decreased in the ischemic leg compared with the nonischemic contralateral leg (2.4 Ϯ 0.2 vs. 3.8 Ϯ 0.3 mol O 2 ·min Ϫ1 ·g dry wt Ϫ1 , P ϭ 0.006; 2.6 Ϯ 0.4 vs. 4.2 Ϯ 0.5 mol O 2 ·min Ϫ1 ·g dry wt Ϫ1 , P ϭ 0.02; 5.7 Ϯ 0.5 vs. 7.9 Ϯ 0.5 mol O 2 ·min Ϫ1 ·g dry wt Ϫ1 , P ϭ 0.04, respectively).
DISCUSSION
The main results of this study show, for the first time, that pretreatment with BNP protects skeletal muscle against IR-induced deleterious effects. In addition to restoring mitochondrial respiratory chain complex activities, the mechanisms involved in BNP protection likely associate reduced reactive oxygen production and mK ATP channel opening. Such protection is ineffective, however, when BNP is administered during ischemia. 
IR Impairs Mitochondrial Respiratory Chain Complex Activities, Increases ROS Production, and Likely Increases Apoptosis
Measurements of mitochondrial function allow assessment of functional metabolic impairments of skeletal muscle, and the respiratory rate in skinned fibers is a unique means to measure the functional oxidative capacity of the entire mitochondrial population within its cellular environment.
Confirming previous data (44, 45) , this study demonstrates that 3-h ischemia followed by 2-h reperfusion significantly decreased mitochondrial function in the glycolytic gastrocnemius muscle, a muscle readily mimicking the metabolic characteristics of deconditioned human skeletal muscle (3). On further exploring the functional activity of the different complexes, we observed a global impairment of the mitochondrial respiratory chain. Several mechanisms may contribute to these IR-induced deleterious effects, although increased oxidative stress appears to be a key factor (6) . Indeed, the mitochondrial respiratory chain is one of the main sources of endogenous ROS, while the electron transport chain, which is central to the oxidative production of ATP in cells, has been shown to play an important role in oxidative stress injury. In particular, mitochondrial complex inhibition is known to increase ROS generation (7) . Such increase in ROS production, in turn, exacerbates mitochondrial dysfunction and further induces oxidative damage to lipids and proteins, leading to alterations in major cell constituents and apoptosis (10, 18, 21, 36) .
Apoptosis is widely recognized as an important cause of cell death after reperfusion in the myocardium (12), whereas much less and often controversial data are available in skeletal muscle (8, 23, 20, 49) . Our results support the notion that IR induces an apoptotic process in skeletal muscle, as inferred from the greater Bax/Bcl2 mRNA in ischemic vs. shamoperated muscles. However, caspase-3 activity failed to change significantly in the four groups studied. Caspase-3 activity is considered as a good marker of apoptosis, and thus we expected an increase after IR and normalization after BNP pretreatment. Our study design may be at the basis of this discrepancy. Indeed, while the increase in Bax/Bcl2 mRNA occurs early in the setting of IR, caspase-3 is involved later in the apoptotic cascade. Thus 2 h of reperfusion may have been too short to quantify changes in caspase-3. Accordingly, in a canine model of myocardial IR subjected to 60 min of left anterior descending coronary occlusion, Zhao et al. observed a progressive occurrence of apoptosis from 6 to 72 h of reperfusion through detection of terminal transferase-mediated dUTP nick end-labeling-positive cells (51) . Moreover, Tran et al. (47) recently reported tourniquet-induced apoptosis using caspase-3 activity measurement in mouse skeletal muscle following 3-h ischemia and 4-h reperfusion. Therefore, although requiring confirmation, we believe that apoptosis is involved in the deleterious effects of IR on skeletal muscle.
Pretreatment with BNP Protects Mitochondrial Respiratory Chain Complex Activities and Likely Prevents Skeletal Muscle Apoptosis
In this study, we demonstrate that BNP protects the mitochondrial respiratory function of skeletal muscle from IR injuries. BNP also likely prevents apoptosis. Indeed, mitochondrial respiratory chain complex activities were restored, and BNP decreased proapoptotic Bax mRNA gene expression while increasing antiapoptotic Bcl2 mRNA gene expression, thereby decreasing the Bax/Bcl2.
Ischemic pre-or postconditioning has been shown to protect muscle mitochondrial function against IR-induced deleterious effects (6, 44) . However, pharmacological conditioning is easier to perform in a clinical setting. Unlike renin-angiotensin-aldosterone inhibitors, which have been shown to be ineffective (46) , BNP appears as a good candidate. Indeed, in addition to the protection demonstrated in this study, BNP also displays beneficial renal and cardiovascular effects in the setting of cardiac surgery and transplantation (13, 16, 17, 52) .
With regard to apoptosis, our results are in agreement with the data of Fiscus et al. (14) , showing an antiapoptotic effect of BNP in PC12 cells. Similarly, others have also highlighted the antiapoptotic properties of BNP on cardiomyocytes in culture submitted to IR (42) .
Knowing that ROS largely participates in the deleterious effects of IR and that BNP reduces the extent of myocardial infarction after coronary occlusion through mK ATP channel opening (11), we investigated whether similar mechanisms could participate in the protection afforded by BNP on skeletal muscles.
Involvement of ROS and mK ATP Channels in the Protective Effects of BNP
Lower DHE staining in IR skeletal muscle pretreated with BNP strongly supports the role of this cardiac hormone in decreasing oxidative stress. Since BNP herein reduced IRinduced mitochondrial dysfunction, the resulting reduced oxidative stress could be related, at least in part, to a better functioning of the mitochondrial respiratory chain, thereby reducing ROS overproduction (54) . Consistently, cardiomyocytes in culture submitted to IR (42) , as well as cardiac fibroblasts of newborn rats, have demonstrated a beneficial dose-dependent effect of natriuretic peptide against ROS overproduction (24) .
As in the myocardium (11), mK ATP channels may be involved in the protective effect of BNP against the deleterious effects of IR on skeletal muscle. Indeed, when 5-HD was administered in rats before BNP, impairments in mitochondrial respiratory chain complex activities were observed, as were increased apoptosis and ROS overproduction. Accordingly, in L6 skeletal muscle myoblasts and rat skeletal muscle mitochondria, potassium channel opener modulation of oxidative phosphorylation was abolished by glibenclamide, a wellknown nonselective K ATP channel inhibitor (9) . In C2C12 myotubes, in the setting of preconditioning-induced cytoprotection, mitochondrial-enhanced oxygen consumption was attenuated by 5-HD (29) . This cytoprotection is seemingly attributed to mK ATP channels, since diazoxide, via opening of specific mK ATP channels, was found to preserve mitochondrial respiratory function, reduces the output of ROS, as well as displays antiapoptotic properties (39) , all of which were abolished by 5-HD (1). Diazoxide was also found to display similar effects in rat skeletal myoblasts, improving cell survival under oxidant stress in vitro, and in infarcted rat heart transplanted with myoblasts in vivo (32) . Although the selectivity of 5-HD for mK ATP channels remains a matter of debate and that 5-HD may also act on other intracellular targets (19), we cannot rule Ischemia-Reperfusion in Skeletal Muscle and BNP Protection • Talha S et al. out the cytoprotective effect of BNP on skeletal muscle, as least in part, by favoring mK ATP channel opening.
Study Limitations
Despite adding caspase-3 activities to Bax/Bcl2 mRNA measurements, the apoptosis pathway has not been fully assessed in this work. The lack of change in caspase-3 may be related to the relatively short period of reperfusion and longer period of reperfusion might have been useful. Further analysis of caspase-9, which is involved earlier in the apoptotic cascade, may be preferable in this instance.
Moreover, we were able to show that BNP protects mitochondrial respiratory chain complex activities when injected before ischemia, but not during the ischemic episode. This could limit the therapeutic potential of BNP after insult, and BNP is thus more likely to act as a pharmacological preconditioner.
Moreover, it would be of interest to identify the signaling pathway leading BNP to mK ATP channels opening, including the nature of the protein kinases involved and the presence of a potential, albeit still unknown, BNP receptor in skeletal muscle. A cellular approach may prove valuable in this context.
Perspectives
The results of our experimental study showing protective effects of BNP on IR-induced mitochondrial respiratory complex damage, ROS production, and proapoptotic effect are encouraging in view of its relevance in humans. Indeed, human skeletal muscle impairments are frequent, and, while sometimes subtle, they significantly participate in patient morbidity and mortality (27, 28) . In human skeletal muscles, acute and chronic ischemias have been shown to induce mitochondrial dysfunctions (3, 35) .
Although BNP failed to be protective when administrated during ischemia, exogenous BNP administration could prove useful in protecting muscle function in the setting of planned and relatively long periods of ischemia followed by reperfusion. This is observed in frequent surgical procedures, such as aortic aneurysm repair and reconstructive surgery with flap tissue transfer (22) .
Conclusions
This study demonstrates, for the first time, in skeletal muscle that BNP is able to prevent IR-induced injuries, such as impaired mitochondrial respiratory chain complex activities, ROS production, and apoptosis. Furthermore, this protective effect of BNP on IR-induced injuries possibly involves mK ATP channel opening. Since even subtle muscle impairments are associated with increased morbidity and mortality, further clinical studies are warranted to determine the clinical usefulness of BNP in the many settings of muscle IR, including crush syndrome, complex vascular surgery, or muscle flap procedures.
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